Influence of Methylenetetrahydrofolate Reductase C677T, A1298C, and G80A Polymorphisms on the Survival of Pediatric Patients with Acute Lymphoblastic Leukemia
Figure 2
Frequency of MTX plasma levels of methotrexate in patients with genotype of the G80A polymorphism at 24 h and 48 h of clearance, by Kruskal Wallis test ().
